Bacterial Anti-adhesives: Inhibition of Staphylococcus aureus Nasal Colonization

ACS Infectious Diseases
Allison C LeonardGeorgina Cox

Abstract

Bacterial adhesion to the skin and mucosa is often a fundamental and early step in host colonization, the establishment of bacterial infections, and pathology. This process is facilitated by adhesins on the surface of the bacterial cell that recognize host cell molecules. Interfering with bacterial host cell adhesion, so-called anti-adhesive therapeutics, offers promise for the development of novel approaches to control bacterial infections. In this review, we focus on the discovery of anti-adhesives targeting the high priority pathogen Staphylococcus aureus. This organism remains a major clinical burden, and S. aureus nasal colonization is associated with poor clinical outcomes. We describe the molecular basis of nasal colonization and highlight potentially efficacious targets for the development of novel nasal decolonization strategies.

References

Oct 1, 1982·The Journal of Investigative Dermatology·D J BibelW G Strauss
Jun 22, 1999·Infection and Immunity·R O NicholasD R Gentry
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·S K MazmanianO Schneewind
Nov 4, 2000·Expert Opinion on Investigational Drugs·C G Kelly, J S Younson
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Jul 5, 2001·International Journal of Medical Microbiology : IJMM·S Arvidson, K Tegmark
Feb 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M Garrouste-OrgeasJ Carlet
Apr 12, 2002·Chembiochem : a European Journal of Chemical Biology·A SvenssonJ Kihlberg
Apr 16, 2002·Molecular Microbiology·John M Taylor, David E Heinrichs
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Jul 23, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Ambrose L Cheung, Gongyi Zhang
Jan 4, 2003·Journal of Bacteriology·B Saïd-SalimB N Kreiswirth
Apr 5, 2003·Skin Pharmacology and Applied Skin Physiology·J J Wille, A Kydonieus
Oct 3, 2003·FEMS Immunology and Medical Microbiology·Itzhak OfekNathan Sharon
Feb 6, 2004·The Journal of Antimicrobial Chemotherapy·William J WeissLefa Alksne
Feb 26, 2004·Molecular Microbiology·Simon R ClarkeSimon J Foster
Mar 26, 2004·Nature Reviews. Microbiology·James B KaperHarry L Mobley
Apr 28, 2004·FEMS Microbiology Reviews·Stéphane BronnerGilles Prévost
Mar 8, 2005·Infection·J A J W Kluytmans, H F L Wertheim
Sep 13, 2005·Bioorganic & Medicinal Chemistry Letters·Ki-Bong OhJongheon Shin
Oct 6, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Hirofumi TakigawaGenji Imokawa
Nov 18, 2005·Journal of Bacteriology·Maria Magdalena SennMarkus Bischoff
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Dec 13, 2005·Microbiology and Molecular Biology Reviews : MMBR·Mark J KazmierczakKathryn J Boor
Apr 25, 2006·FEMS Microbiology Letters·Majlis SvenssonCatharina Svanborg
Oct 18, 2006·Biochemistry·Christie L VermeirenMartin J Stillman
Jan 19, 2007·Molecular Microbiology·Jason C GriggMichael E P Murphy
Feb 13, 2007·Biochimica Et Biophysica Acta·O LópezA de la Maza
Apr 28, 2007·Microbiology·Adhar C Manna, Binata Ray
Jun 7, 2007·Organic & Biomolecular Chemistry·Veronica Aberg, Fredrik Almqvist
Dec 14, 2007·Nature·James A Wells, Christopher L McClendon
Jan 18, 2008·PLoS Medicine·Heiman F L WertheimAlex van Belkum
Jan 29, 2008·International Journal of Medical Microbiology : IJMM·Christopher WeidenmaierAndreas Peschel
Jan 30, 2008·Infection and Immunity·Simon R Clarke, Simon J Foster

❮ Previous
Next ❯

Citations

Feb 20, 2021·Canadian Journal of Microbiology·Celine Stoica, Georgina Cox
Jul 15, 2021·FEMS Microbiology Reviews·Elisa J M RaineriJan Maarten van Dijl
Sep 17, 2021·Animal Microbiome·Cameron T PerryFrank J Stewart
Oct 1, 2021·Genes and Immunity·Ann-Kathrin MixChristof R Hauck

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Respiration; International Review of Thoracic Diseases
C Bavington, C Page
© 2021 Meta ULC. All rights reserved